Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene-Reference-Cited by-同舟云学术

Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene

Published:2020-06 Issue: Volume:126 Page:110107
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Sun Siyu,Fang Wenjia

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference135 articles.

1. T-cell prolymphocytic leukemia;Dearden;Med. Oncol.,2006

2. T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role of cytogenetics: a multidisciplinary approach;Tirado;Exp. Hematol. Oncol.,2012

3. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia;Matutes;Blood,1991

4. Exploring the molecular pathogenesis associated with T-cell prolymphocytic leukemia based on a comprehensive bioinformatics analysis;Shi;Oncol. Lett.,2018

5. Cytogenetic studies on prolymphocytic leukemia. II. T cell prolymphocytic leukemia;Brito-Babapulle;Blood,1987

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disseminated Cryptococcosis With Prostate Involvement in a Patient With T-cell Prolymphocytic Leukemia and Prostate Cancer;Cureus;2024-06-02

2. TCL1A-expressing B cells are critical for tertiary lymphoid structure formation and the prognosis of oral squamous cell carcinoma;Journal of Translational Medicine;2024-05-19

3. Case report: CD8 positive T-cell Prolymphocytic Leukemia presenting complex karyotype with a rare chromosomal abnormality der(2)t(1;2)(q21;q37) and additional signals of the genes MYC, IGH, and TP53;Hematology, Transfusion and Cell Therapy;2023-08

4. Delineation of clinical course, outcomes, and prognostic factors in patients with T‐cell prolymphocytic leukemia;American Journal of Hematology;2023-04-03

5. Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia;PLOS ONE;2022-09-21